Chemed CHE Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.
The official record: Chemed’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Chemed's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Chemed's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value?
- Chemed (CHE) reported share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value of 85.8 in Q4 2025.
- How has Chemed's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value changed year-over-year?
- Chemed's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value decreased by 25.1% year-over-year, from 114.6 to 85.8.
- What does share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value mean?
- The weighted average fair value of stock options granted during the reporting period, calculated using an option-pricing model. This metric is used to determine the total compensation expense that will be recognized over the vesting period of the awards.